Literature DB >> 22362048

Pure spinal epidural cavernous hemangioma.

Weiying Zhong1, Siqing Huang, Haifeng Chen, Hong Sun, Bowen Cai, Yi Liu, Chao You.   

Abstract

BACKGROUND: Pure epidural cavernous hemangiomas without bony involvement are rare, representing 4% of all spinal epidural tumors. Most of these are case reports and are easily misdiagnosed.
METHODS: Herein nine patients (male:female, 5:4, average age: 51 years) with symptomatic pure epidural spinal cavernous hemangioma between 2005 and 2011 were treated, and the clinical, radiological, and pathological records, treatment, and prognosis were discussed.
RESULTS: All patients experienced a slowing progressive clinical course, except for one with intralesional hemorrhage. Clinical manifestations included back or radiating pain, sensorimotor deficits, and sphincters disturbance. Eight lesions were isointense on T1- and hyperintense on T2-weighted images with homogenously strongly enhancement and one was mixed signal with heterogeneous enhancement because of intratumoral hemorrhage. Hemilaminotomoy or laminotomy was performed and total resection was achieved. All patients experienced a gradual neurological improvement with no recurrence.
CONCLUSIONS: Spinal epidural cavernous hemangioma is a benign vascular malformation that should be excluded in the diagnosis of epidural lesion. Total surgical resection is recommended and usually results in a good prognosis.

Entities:  

Mesh:

Year:  2012        PMID: 22362048     DOI: 10.1007/s00701-012-1295-3

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  12 in total

1.  Pure spinal epidural cavernous hemangioma with intralesional hemorrhage: a rare cause of thoracic myelopathy.

Authors:  Donghwan Jang; Choonghyo Kim; Seung Jin Lee; Young-Joon Ryu; Jiha Kim
Journal:  Korean J Spine       Date:  2014-06-30

2.  Thoracic extraosseous epidural cavernous hemangioma.

Authors:  Can Yaldiz; Kiyasettin Asil; Davut Ceylan; Sahin Erdem
Journal:  J Korean Neurosurg Soc       Date:  2015-01-31

3.  Pure extraosseous spinal epidural cavernous hemangioma presenting with acute paraplegia: a case report.

Authors:  Kaoru Eguchi; Aayush R Malhotra; Armaan K Malhotra; Erin M Harrington; David G Munoz; Yusuke Nishimura; Jefferson R Wilson; Christopher D Witiw
Journal:  Spinal Cord Ser Cases       Date:  2022-06-30

4.  Clinical characteristics and surgical outcomes of solitary spinal epidural cavernous angiomas.

Authors:  Tao Yang; Fei Wang; Chaoshi Niu
Journal:  Oncol Lett       Date:  2018-02-12       Impact factor: 2.967

Review 5.  Clinical and radiological presentation of spinal epidural haemangiomas: clinical series in a tertiary care centre during a 10-year period.

Authors:  Mario Mühmer; Richard Bostelmann; Sevgi Sarikaya-Seiwert; Marcel Schneiderhan; Hans-Jakob Steiger; Jan Frederick Cornelius
Journal:  Eur Spine J       Date:  2013-10-06       Impact factor: 3.134

6.  Extraosseous, epidural cavernous hemangioma with back pain.

Authors:  Birol Ozkal; Can Yaldiz; Onur Yaman; Nail Ozdemır; Sedat Dalbayrak
Journal:  Pol J Radiol       Date:  2015-04-22

7.  Imaging in spinal posterior epidural space lesions: A pictorial essay.

Authors:  Foram B Gala; Yashant Aswani
Journal:  Indian J Radiol Imaging       Date:  2016 Jul-Sep

8.  Pure spinal epidural cavernous hemangioma: A case series of seven cases.

Authors:  Ignatius Ngene Esene; Ahmed M Ashour; Eric Marvin; Mohamed Nosseir; Zeiad Y Fayed; Khaled Seoud; Khaled El Bahy
Journal:  J Craniovertebr Junction Spine       Date:  2016 Jul-Sep

Review 9.  Epidural cavernous haemangioma during pregnancy: a case report and a literature review.

Authors:  Anas Bennis; Reda Hafiane; Jaafar Benouhoud; Amine El Khaoudi; Khadija Ibahioin; Abdelhakim Lakhdar; Ihsane Moussaid; Smaïl El Youssoufi; Said Salmi
Journal:  Pan Afr Med J       Date:  2019-07-15

10.  MRI features of spinal epidural angiolipomas.

Authors:  Su Hu; Chun-hong Hu; Xiao-yun Hu; Xi-ming Wang; Hui Dai; Xiang-ming Fang; Lei Cui
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.